하이텍팜

Dear Valued Customers and Shareholders,

Since its establishment in 1998, High Tech Pharm has devoted itself to the production of active pharmaceutical ingredients (APIs) and quality innovation, driven by a commitment to improving human health.

As a result, we have established a distinctive position as a specialized manufacturer of technically demanding Carbapenem antibiotic APIs, and today, we proudly stand as the world’s leading company in this field.

In particular, our Chungju Plant serves as the cornerstone of High Tech Pharm’s next phase of growth. Designed from the outset to meet the stringent requirements of major regulated markets, including the United States, Europe, and Japan, the facility is equipped with world-class manufacturing capacity and quality management capabilities. It provides a strong foundation for our continued expansion and success in the global marketplace.

Our world-class manufacturing processes and quality management systems are driven not only by business objectives but also by a profound sense of responsibility to ensure that safe and effective medicines are delivered to patients around the world.

High Tech Pharm will continue to place quality as our highest priority and strive to be a company that fulfills its social responsibility based on principles and trust.

We are also committed to transparent management grounded in strong ethical standards, strengthening the sustainability and resilience of our business, and maintaining a shareholder-friendly approach by ensuring that the value created through our growth is shared with our shareholders and customers.

High Tech Pharm is determined not to rest on its current achievements. Building upon our accumulated expertise in API manufacturing and our proven quality competitiveness, we will continue to discover new growth opportunities. Through the development of new pharmaceutical products and the expansion of our pipeline, we aim to broaden our business scope and take another step forward as a global pharmaceutical company dedicated to creating a healthier future.

We will continue to pursue innovation and embrace new challenges in order to earn the trust of our customers, shareholders, employees, and society as a whole.

We sincerely ask for your continued support and encouragement as High Tech Pharm embarks on this new journey.
Thank you.

Scott Cha

We have strengthened product competitiveness by implementing a quality-first policy and supplying more than 95% of sales to overseas markets such as Europe. The future of carbapenem antibiotics is expected to expand rapidly, so I think the future of the company will be brighter.

We do not settle for the present. With the goal of becoming a leading global drug substance company, we promise to take a leap forward in the field of drug substance through research and development of antibiotic drug substances based on our advanced technology accumulated over many years. High Tech Pharm is doing its best to produce and supply the world's highest quality in raw material medicine. We will not cease to challenge ourselves to develop the highest quality carbapenem antibiotic drugs.